Abiopharma

Clinical trial NCT04905316 updates: 1. completion date: 2026-05-01 → 2027-05-01 2. primary completion date: 2026-05-01 → 2027-05-01

Clinical trial NCT04036682 updates: 1. completion date: 2026-03-31 → 2028-03-31 2. primary completion date: 2026-01-31 → 2025-10-13 3. collaborators added: Taiho Oncology, Inc.

Clinical trial NCT03132792 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-07 → 2025-11-19 3. enrollment: 45 → 39 participants

Clinical trial NCT07589595 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-05-20

Clinical trial NCT06574984 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-04-30 → 2025-11-04 3. primary completion date: 2026-02-27 → 2025-11-04 4. enrollment: 900 → 329 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT03113643: primary completion date: 2026-05-31 → 2021-09-15.

Clinical trial NCT07209787 updates: 1. start date: 2025-09-11 → 2025-10-21 2. collaborators added: Jiangsu Taizhou People's Hospital 3. collaborators removed: Taizhou People's Hospital

Clinical trial NCT07477691 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-03-31 → 2026-05-29

Clinical trial NCT07339384 updates: 1. start date: 2026-05-01 → 2026-10-01 2. completion date: 2034-05-01 → 2034-10-01 3. primary completion date: 2034-05-01 → 2034-10-01

Clinical trial NCT04400331 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-03-01 → 2025-11-05 3. primary completion date: 2026-03-01 → 2025-11-05